Lisa Carroll

Summary

Affiliation: Western Australia
Country: Australia

Publications

  1. ncbi Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end products
    Lisa Carroll
    Centre for Immunology and Cancer Research, Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia
    Wien Med Wochenschr 156:42-52. 2006
  2. ncbi Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis
    Lisa Carroll
    Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Princess Alexandra Hospital, Ipswich Road, Brisbane, Queensland 4102, Australia
    Arthritis Res Ther 9:R39. 2007

Detail Information

Publications2

  1. ncbi Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end products
    Lisa Carroll
    Centre for Immunology and Cancer Research, Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia
    Wien Med Wochenschr 156:42-52. 2006
    ..The review will conclude with a discussion of the potential role of the RAGE Glycine 82 Serine polymorphism...
  2. ncbi Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis
    Lisa Carroll
    Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Princess Alexandra Hospital, Ipswich Road, Brisbane, Queensland 4102, Australia
    Arthritis Res Ther 9:R39. 2007
    ..Thus, the RAGE Ser82 allele, associated with enhanced RAGE signaling, does not predispose to CV events in RA. However, treatment of hyperlipidemia with statins reduces the probability of a CV event...